May 13th, 2011
ProPublica Takes Aim at SCAI
Larry Husten, PHD
Now it’s SCAI’s turn. Following its investigation of the Heart Rhythm Society’s ties to industry last week, ProPublica has now focused its attention on the Society for Cardiac Angiography and Interventions (SCAI). In the latest installment of ProPublica’s Dollars for Doctors series, Charles Ornstein writes that SCAI “received 57 percent of its revenues in 2009 […]
May 6th, 2011
News Reports Scrutinize Heart Rhythm Society’s Ties To Industry
Larry Husten, PHD
A series of investigative reports published on ProPublica analyzes the financial relationships between medical societies and drug and device companies. The Heart Rhythm Society, whose annual meeting is now taking place in San Francisco, comes in for especially close scrutiny. The series begins: “From the time they arrived to the moment they laid their heads on […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?